Skip to content

The effects of glycogen availability on the skeletal muscle molecular response after concurrent exercise

The effects of glycogen availability on the skeletal muscle molecular response after concurrent exercise - Glycogen and concurrent exercise

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON42458
Enrollment
14
Registered
2015-11-16
Start date
2015-12-07
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect van inspanning met lage glycogeenbeschikbaarheid op de moleculaire respons Not applicable

Interventions

Intervention: Two experimental exercise sessions. During both experimental days subjects will complete an endurance exercise bout in the morning (8.30am) followed by a resistance exercise session in

Sponsors

Wageningen Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Male gender between 18 and 30 years of age • BMI between 18.5 - 25 kg/m2 • Participating in regular exercise training (at least 1 exercise session, and a maximum of 3 exercise session per week) • Used to different types of exercise (endurance, resistance and/or concurrent) • Willing to give blood samples • Willing to give muscle biopsies • No use of antibiotics during the study or in the past month • No drug use • Suitable veins for blood withdrawal • Registered by a general-practitioner • Consumption of alcohol beverages is less than 21 per week • No blood donor during the study • No vegetarian and willing to eat meat during the experimental days • Able to be present and participate at both test days and pre testing moments • Not employed, or intern, or working on thesis at the department of Human Nutrition at Wageningen University • Not participating in another scientific study (except EetMeetWeet) • Able to participate during the experimental days en pre tests • Able to speak Dutch

Exclusion criteria

Exclusion criteria: • Medical condition that can interfere with the study outcome (i.e. cardiovascular disease, pulmonary disease, gluten intolerance) • Systolic blood pressure >160 mmHg and/or diastolic blood pressure >100 mmHg • Use of medications known to interfere with gene expression in the muscles (i.e. statins, fenofibrate) • Use of antithrombotic therapy (marcoumar, sintromitis). • Diagnosed diabetes mellitus type 1 or 2 • (Chronic) injuries of the locomotor system that can interfere with the intervention

Design outcomes

Primary

MeasureTime frame
- Phosphorylation of intramuscular proteins - Changes in mRNA expression

Secondary

MeasureTime frame
- A spectrum of post exercise myokines, cytokines and myogenic regulatory factors will be measured. - Muscle glycogen - Glucose, insulin, free fatty acids, cortisol, adrenalin and lactate - Perceived exertion

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)